Alaaeldin, R.; Ali, F.E.M.; Bekhit, A.A.; Zhao, Q.-L.; Fathy, M.
Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. Molecules 2022, 27, 7825.
https://doi.org/10.3390/molecules27227825
AMA Style
Alaaeldin R, Ali FEM, Bekhit AA, Zhao Q-L, Fathy M.
Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. Molecules. 2022; 27(22):7825.
https://doi.org/10.3390/molecules27227825
Chicago/Turabian Style
Alaaeldin, Rania, Fares E. M. Ali, Amany Abdlrehim Bekhit, Qing-Li Zhao, and Moustafa Fathy.
2022. "Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan" Molecules 27, no. 22: 7825.
https://doi.org/10.3390/molecules27227825
APA Style
Alaaeldin, R., Ali, F. E. M., Bekhit, A. A., Zhao, Q. -L., & Fathy, M.
(2022). Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. Molecules, 27(22), 7825.
https://doi.org/10.3390/molecules27227825